Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126180111 | 12618011 | 1 | I | 20080406 | 20100216 | 20160803 | 20160803 | EXP | GB-ASTELLAS-2010000560 | ASTELLAS | 80.91 | YR | F | Y | 0.00000 | 20160803 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126180111 | 12618011 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | 3900 | MG | 0 | 150 | MG | FORMULATION UNKNOWN | QD | |||||
126180111 | 12618011 | 2 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 2 | MG | FORMULATION UNKNOWN | |||||||
126180111 | 12618011 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 4 | MG | FORMULATION UNKNOWN | |||||||
126180111 | 12618011 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 6 | MG | FORMULATION UNKNOWN | |||||||
126180111 | 12618011 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | 20 | MG | FORMULATION UNKNOWN | QD | ||||||
126180111 | 12618011 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | U | 0 | 200 | MG | FORMULATION UNKNOWN | BID | ||||||
126180111 | 12618011 | 7 | C | MORPHINE | MORPHINE | 1 | Oral | U | 0 | 10 | DF | FORMULATION UNKNOWN | |||||||
126180111 | 12618011 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | U | 0 | 75 | MG | FORMULATION UNKNOWN | |||||||
126180111 | 12618011 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | U | 0 | 10 | MG | FORMULATION UNKNOWN | QD | ||||||
126180111 | 12618011 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 0 | 500 | MG | FORMULATION UNKNOWN | TID | ||||||
126180111 | 12618011 | 11 | C | VALSARTAN. | VALSARTAN | 1 | Oral | U | 0 | 80 | MG | FORMULATION UNKNOWN | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126180111 | 12618011 | 1 | Non-small cell lung cancer |
126180111 | 12618011 | 2 | Product used for unknown indication |
126180111 | 12618011 | 5 | Product used for unknown indication |
126180111 | 12618011 | 6 | Product used for unknown indication |
126180111 | 12618011 | 7 | Product used for unknown indication |
126180111 | 12618011 | 8 | Product used for unknown indication |
126180111 | 12618011 | 9 | Product used for unknown indication |
126180111 | 12618011 | 10 | Product used for unknown indication |
126180111 | 12618011 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126180111 | 12618011 | DE |
126180111 | 12618011 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126180111 | 12618011 | Death | |
126180111 | 12618011 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126180111 | 12618011 | 1 | 20080306 | 20080331 | 0 |